Veronique Belzil MS, PhD

Veronique Belzil, Ph.D., M.S., works on developing individualized approaches to treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and other related neurodegenerative diseases. Her laboratory aims to discover and characterize genetic, epigenetic and transcriptional changes driving neuronal death to better understand the complex etiology, heterogeneous clinical presentation, comorbid conditions and multifaceted environmental interaction observed in patients with neurodegenerative diseases.

Dr. Belzil's research group uses human biospecimens and integrative multiomic approaches to systematically identify disease-specific variants, elucidate their underlying mechanisms of action, shed light on distinct circuitry, and ultimately uncover static and dynamic biomarkers and putative therapeutic targets. Her lab also works on developing therapeutic approaches using gene delivery, gene silencing, gene editing and RNA interference methods in patient-derived cell lines.